127 related articles for article (PubMed ID: 8923609)
1. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy.
Söderkvist P; Ahmadi A; Akerbäck A; Axelson O; Flodin U
Scand J Work Environ Health; 1996 Oct; 22(5):360-3. PubMed ID: 8923609
[TBL] [Abstract][Full Text] [Related]
2. Interaction between smoking and glutathione S-transferase polymorphisms in solvent-induced chronic toxic encephalopathy.
Ahmadi A; Jönsson P; Flodin U; Söderkvist P
Toxicol Ind Health; 2002 Jul; 18(6):289-96. PubMed ID: 14992466
[TBL] [Abstract][Full Text] [Related]
3. [The role of smoking and metabolic enzyme polymorphisms in the organic solvent induced chronic encephalopathy].
Wang HY; Ma YM; Cui JZ; Zhao D; Liu AJ; Hong J; Lu YG; Wang KJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Mar; 34(3):199-202. PubMed ID: 27220440
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems.
Landtblom AM; Wastenson M; Ahmadi A; Söderkvist P
Neurol Sci; 2003 Nov; 24(4):248-51. PubMed ID: 14658041
[TBL] [Abstract][Full Text] [Related]
5. Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1, and T1 polymorphisms increase the risk of bladder cancer? The Belgrade case-control study.
Matic MG; Coric VM; Savic-Radojevic AR; Bulat PV; Pljesa-Ercegovac MS; Dragicevic DP; Djukic TI; Simic TP; Pekmezovic TD
PLoS One; 2014; 9(6):e99448. PubMed ID: 24914957
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of prenatal solvent exposure and GSTT1 or GSTM1 polymorphisms in the risk of birth defects.
Garlantézec R; Chevrier C; Coiffec I; Celebi C; Cordier S
Birth Defects Res A Clin Mol Teratol; 2012 Jun; 94(6):481-5. PubMed ID: 22570144
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
[TBL] [Abstract][Full Text] [Related]
8. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers.
Pavanello S; Pulliero A; Siwinska E; Mielzynska D; Clonfero E
Carcinogenesis; 2005 Jan; 26(1):169-75. PubMed ID: 15471894
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphism of GSTP1, GSTT1, GSTM1 and CYP2E1 genes and susceptibility to benzene-induced hematotoxicity.
Nourozi MA; Neghab M; Bazzaz JT; Nejat S; Mansoori Y; Shahtaheri SJ
Arch Toxicol; 2018 Jun; 92(6):1983-1990. PubMed ID: 29204680
[TBL] [Abstract][Full Text] [Related]
10. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.
Bell DA; Taylor JA; Paulson DF; Robertson CN; Mohler JL; Lucier GW
J Natl Cancer Inst; 1993 Jul; 85(14):1159-64. PubMed ID: 8320745
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
Asian Pac J Cancer Prev; 2005; 6(3):270-5. PubMed ID: 16235985
[TBL] [Abstract][Full Text] [Related]
13. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals.
Buzio L; De Palma G; Mozzoni P; Tondel M; Buzio C; Franchini I; Axelson O; Mutti A
Occup Environ Med; 2003 Oct; 60(10):789-93. PubMed ID: 14504370
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of exposure, effect, and susceptibility.
Heuser VD; Erdtmann B; Kvitko K; Rohr P; da Silva J
Toxicology; 2007 Apr; 232(3):235-47. PubMed ID: 17292523
[TBL] [Abstract][Full Text] [Related]
16. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
[TBL] [Abstract][Full Text] [Related]
17. Association between GSTM1, GSTT1, and GSTP1 variants and the risk of end stage renal disease.
Nomani H; Hagh-Nazari L; Aidy A; Vaisi-Raygani A; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Mozaffari HR; Tavilani H; Pourmotabbed T
Ren Fail; 2016 Oct; 38(9):1455-1461. PubMed ID: 27498857
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
Törüner GA; Akyerli C; Uçar A; Aki T; Atsu N; Ozen H; Tez M; Cetinkaya M; Ozçelik T
Arch Toxicol; 2001 Oct; 75(8):459-64. PubMed ID: 11757669
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD.
Cheng SL; Yu CJ; Chen CJ; Yang PC
Eur Respir J; 2004 Jun; 23(6):818-24. PubMed ID: 15218992
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility in solvent induced neurobehavioral effects.
Godderis L; Maertens N; de Gelder V; De Lamper A; De Ruyck K; Vernimmen M; Bulterys S; Moens G; Thierens H; Viaene MK
Neurotox Res; 2010 Apr; 17(3):268-78. PubMed ID: 19701675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
